Peptide Therapeutics, Medeva deal

By WIR Staff | Apr 15, 2013 | 7:00 AM GMT

MDV transferred to PTE a portfolio of non-injectable vaccine delivery

Read the full 101 word article

How to gain access

Continue reading with a
two-week free trial.